← Leaderboards
Avraham Beigelman
Washington University
$2,521,583
Attributed
$3,685,731
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $819.4K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,685,731 · 1
By mechanism
R01$3,685,731 · 1
Top collaborators
- Leonard B Bacharier3 shared
- Mythili Srinivasan1 shared
Most similar at Washington University
Same institution · by research overlap
- Mario Castro$45,956,792
- Thalachallour Mohanakumar$18,846,664
- Michael Jay Holtzman$55,932,256
- Stuart C Sweet$14,692,756
- Leonard B Bacharier$9,616,060
Others in their field
Top investigators on “Genome”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomeAnti-Bacterial AgentsEffective InterventionAsthmaAsthma PreventionAttenuatedAzithromycinAirway InflammationBaseBronchiolitisCaringChildhoodChildhood AsthmaChronic DiseaseClinical ResearchClinical TrialsBacteriaAntibioticsCommunicable DiseasesCommunitiesCystic FibrosisDiagnosisDiffuseHealth Care Service Utilization
Grant awards (6)
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$673,248
R01 · FY2020 · HL · contact PI
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$697,570
R01 · FY2019 · HL · contact PI
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$733,063
R01 · FY2018 · HL · contact PI
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$749,986
R01 · FY2017 · HL · contact PI
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$69,366
R01 · FY2017 · HL · contact PI
AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$762,498
R01 · FY2016 · HL · contact PI